Patient socioeconomic determinants for the choice of the cheapest molecule within a cluster: Evidence from Belgian prescription data

European Journal of Health Economics

Volumn 13, Issue 3, 2012, Pages 315-325

  Vrijens, France ^a   Van De Voorde, Carine ^a   Farfan Portet, Maria Isabel ^a   Stichele, Robert Vander ^b  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

Belgium; Cost sharing; Pharmaceuticals; Reference pricing; Reimbursement; Socioeconomic factors

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATORVASTATIN; BENAZEPRIL; CANDESARTAN; CAPTOPRIL; CILAZAPRIL; DIURETIC AGENT; ENALAPRIL; EPROSARTAN; ESOMEPRAZOLE; FLUINDOSTATIN; FOSINOPRIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRBESARTAN; LANSOPRAZOLE; LISINOPRIL; LOSARTAN; OMEPRAZOLE; PANTOPRAZOLE; PERINDOPRIL; PRAVASTATIN; PROTON PUMP INHIBITOR; QUINAPRIL; RABEPRAZOLE; RAMIPRIL; ROSUVASTATIN; SIMVASTATIN; TELMISARTAN; UNINDEXED DRUG; VALSARTAN;

ADULT; AGED; ARTICLE; BELGIUM; CHRONIC DISEASE; DRUG COST; DRUG USE; EDUCATIONAL STATUS; EMPLOYMENT; FEMALE; FINANCIAL MANAGEMENT; GENERAL PRACTITIONER; GERIATRIC PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NURSING HOME; PATIENT ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REIMBURSEMENT;

BELGIUM; CLUSTER ANALYSIS; CONFIDENCE INTERVALS; COST SHARING; HUMANS; INSURANCE CLAIM REVIEW; INSURANCE, HEALTH, REIMBURSEMENT; INSURANCE, PHARMACEUTICAL SERVICES; LOGISTIC MODELS; MOTIVATION; ODDS RATIO; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; SOCIOECONOMIC FACTORS;

EID: 84861191857     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-011-0367-2     Document Type: Article

References (17)

1. Aaserud, M., Dahlgren, A.T., Kosters, J.P., Oxman, A.D., Ramsay, C., Sturm, H.: Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies. Cochrane Database Syst. Rev. 2(2), CD005979 (2006)
2. World Health Organization: ATC Structure and principles (2010)
3. Simoens, S., De Bruyn, K., Bogaert, M., Laekeman, G.: Pharmaceutical policy regarding generic drugs in Belgium. Pharm. Econ. 23(8), 755-766 (2005) (Pubitemid 41420423)
4. Vrijens, F., Van de Voorde, C., Farfan-Portet, M.I., le Polain, M., Lohest, O.: The reference price system and socioeconomic differences in the use of low cost drugs. In: Health Services Research (HSR), vol. 126. Belgian Health Care Knowledge Centre (KCE), Brussels (2010)
5. Farfan-Portet, M.I., Van de Voorde, C., Vrijens, F., Vander Stichele, R.: Patient socioeconomic determinants of the choice of generic versus brand name drugs in the context of a reference price system: evidence from Belgian prescription data. Submitted as companion paper (2011)
6. Adriaen, M., De Witte, K., Simoens, S.: Pricing strategies of originator and generic medicines following patent expiry in Belgium. Journal of Generic Medicines 5(3), 175-187 (2008) (Pubitemid 351560179)
7. National Institute for Health and Disability Insurance (RIZIV/INAMI): [Drugs deliveries in ambulatory sector]. http://www. inami.fgov.be/drug/fr/ statistics-scientific-information/pharmanet/pharmaceutical-tables/pdf/2007/ tables2007.pdf (2007)
8. National Institute for Health and Disability Insurance (RIZIV/INAMI): [Prescription of a minimum percentage of low cost medications - feedback 2009]. http://www.inami.be/care/fr/doctors/promotion-quality/feedbacks/ feedback-generica/feedback 2009.htm (2010)
9. Schneeweiss, S., Soumerai, S.B., Maclure, M., Dormuth, C., Walker, A.M., Glynn, R.J.: Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers. Clin. Pharmacol. Ther. 74(4), 388-400 (2003) (Pubitemid 37222860)
10. The National Association of Statutory Health Insurance Funds [reference prices for medicines]. http://www.gkv-spitzenverband. de/upload/Ü bersicht-Festbetragsfestsetzungen-091106-10031. pdf (2009)
11. Annemans, L., Closon, J.-P., Closon, M.-C., Heymans, I., Lagasse, R.,Mendes da Costa, E., Moureaux, C., Roch, I.: Comparison of the cost and the quality of two financing systems of primary health care in Belgium. In: Health Services Research (HSR), vol. 85. Belgian Health Care Knowledge Centre (KCE), Brussels (2008)
12. Unesco: International Standard Classification of Education (ISCED) - 1997 In. Unesco (2006)
13. Volandes, A.E., Paasche-Orlow, M.K.: Health literacy, health inequality and a just healthcare system. Am J Bioethics AJOB 7(11), 5-10 (2007) (Pubitemid 350129654)
14. Grossman, M.: On the concept of health capital and the demand for health. J. Polit. Econ. 80(2), 223 (1972)
15. Stang, A., Poole, C., Kuss, O.: The ongoing tyranny of statistical significance testing in biomedical research. Eur. J. Epidemiol. 25(4), 225-230 (2010)
16. Schneeweiss, S., Soumerai, S.B., Glynn, R.J., Maclure, M., Dormuth, C., Walker, A.M.: Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization. Can. Med. Assoc. J. 166(6), 737-745 (2002) (Pubitemid 34253122)
17. Duetz, M.S., Schneeweiss, S., Maclure, M., Abel, T., Glynn, R.J., Soumerai, S.B.: Physician gender and changes in drug prescribing after the implementation of reference pricing in British Columbia. Clin. Therap. 25(1), 273-284 (2003) (Pubitemid 36206752)